99m-tc-hynic annexin v
Recombinant proteinexperimentalImaging agent
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2006 (NCT00319059)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Annexin A5Supplementation
ANXA5 supplementation
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 99-MTC
Oral
No
Parenteral
No
Topical
No
Also known as
- 99m-tc-hynic-annexin a5
- 99mtc-hynic-annexin a5
- 99mtc-hynic-annexin a5
- 99m-tc-hynic annexin v
- technetium tc 99m hynic annexin v
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02691078 | Phase 2 | Jul 31, 2016 | Instituto do Cérebro do Rio Grande do Sul - InsCer, Latin American Cooperative Oncology Group |
| NCT00319059 | N/A | Mar 1, 2006 | Radboud University, ZonMw: The Netherlands Organisation for Health Research and Development |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Instituto do Cérebro do Rio Grande do Sul - InsCer | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Latin American Cooperative Oncology Group | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Radboud University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| ZonMw: The Netherlands Organisation for Health Research and Development | Academic/Hospital | 1 | 0 | 1 | 2006 |
4 organizations
Page 1 / 1